Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.

Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.

Abstract: The present invention relates to an adsorbate, comprising an adsorbent and bicalutamide adsorbed on said adsorbent, a process for preparing same, and a pharmaceutical composition thereof.

Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.

Abstract: The present invention relates to a process for the preparation of adsorbates of valsartan and/or its solvates or hydrates wherein one starts with a solution of valsartan or of one of its pharmaceutically acceptable salts and/or their solvates or hydrates in at least one organic solvent where the total water content of the solvent is not higher than 15% by volume, preferably not higher than 5% by volume, disperses therein an adsorbing material selected from the group consisting of celluloses, cellulose derivatives, polyols, sugars, sugar derivatives, maltodextins, cyclodextrins, starches, polydextroses, or their mixtures, and removes the solvent. The invention further relates to valsartan adsorbates that can be prepared with the processes precited, as well as pharmaceutical formulations for the preparation of which the valsartan adsorbates are employed.

Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.

Abstract: The present invention relates to a process for the preparation of powders containing active ingredients in which amorphous tibolone is present in a morphologically stable form, where one starts with a solution of tibolone in at least one organic solvent where the total water content of the solvent is not higher than 15% by volume, preferably not higher than 5% by volume, dissolves therein wholly or in part a carrier material selected from the group of acrylic polymers, and removes the solvent.

Abstract: The present invention relates to the salt of a sulfonic acid with clopidogrel and pharmaceutical formulations comprising this salt.

Abstract: The present invention relates to a process for the preparation of adsorbates of valsartan and/or its solvates or hydrates wherein one starts with a solution of valsartan or of one of its pharmaceutically acceptable salts and/or their solvates or hydrates in at least one organic solvent where the total water content of the solvent is not higher than 15% by volume, preferably not higher than 5% by volume, disperses therein an adsorbing material selected from the group consisting of celluloses, cellulose derivatives, polyols, sugars, sugar derivatives, maltodextins, cyclodextrins, starches, polydextroses, or their mixtures, and removes the solvent. The invention further relates to valsartan adsorbates that can be prepared with the processes precited, as well as pharmaceutical formulations for the preparation of which the valsartan adsorbates are employed.

Abstract: The present invention concerns a process for the preparation of adsorbates and solvates of tibolone where one starts with a solution of tibolone or one of its solvates and/or one of its metabolites in at least one organic solvent where the total water content of the solvent is not higher than 15% by volume, preferably not higher than 5% by volume, disperses therein an adsorbing material selected from the group consisting of celluloses, cellulose derivatives, polyols, sugars, sugar derivatives, maltodextrins, cyclodextrins, starches, polydextroses, or their mixtures, and removes the solvent.

Abstract: The invention relates to a method for the preparation of atorvastatin adsorbates and solvates thereof, wherein one starts from a solution comprising the pharmaceutical active pharmaceutical ingredient substantially dissolved therein, one suspenses an adsorber material therein selected from the group of the celluloses, cellulose derivatives, polyols, sugars, sugar derivatives, maltodextrins, cyclodextrins, starches, polydextroses or mixtures thereof, and one removes the solvent by drying. Also, the invention relates to atorvastatin adsorbates obtainable according to this method as well as pharmaceutical formulations comprising them.